NIOX Group (LON:NIOX) Stock Price Up 0.6% - Should You Buy?

Key Points

• NIOX Group's shares rose 0.6% during mid-day trading, with last traded prices at GBX 71.40 ($0.95), although the trading volume was down 32% compared to its average.
• Wall Street analysts maintain a "buy" rating on NIOX, with a price target of GBX 90 ($1.20) from Deutsche Bank and Berenberg Bank.
• Insider Jonathan Emms sold over 2.7 million shares of the company at an average price of GBX 65 ($0.86), indicating significant insider movement in the stock.

NIOX Group Plc (LON:NIOX - Get Free Report) shares traded up 0.6% during trading on Tuesday . The stock traded as high as GBX 71.60 ($0.96) and last traded at GBX 71.40 ($0.95). 752,352 shares traded hands during mid-day trading, a decline of 32% from the average session volume of 1,112,394 shares. The stock had previously closed at GBX 71 ($0.95).

Analyst Ratings Changes

NIOX has been the topic of several recent analyst reports. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and set a GBX 90 ($1.20) target price on shares of NIOX Group in a research note on Tuesday, April 15th. Berenberg Bank reissued a "buy" rating and set a GBX 90 ($1.20) price target on shares of NIOX Group in a report on Tuesday, April 15th.

NIOX Group Trading Down 3.4%

The business's 50 day moving average price is GBX 68.24 and its two-hundred day moving average price is GBX 65.79. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.94 and a current ratio of 6.31. The company has a market capitalization of £28.34 billion, a price-to-earnings ratio of 2,847.51 and a beta of 0.92.

Insider Activity at NIOX Group

In other news, insider Jonathan Emms sold 2,745,925 shares of the company's stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of GBX 65 ($0.87), for a total value of £1,784,851.25 ($2,384,252.27). Also, insider Ian Johnson bought 144,844 shares of the firm's stock in a transaction that occurred on Wednesday, June 25th. The shares were purchased at an average cost of GBX 8 ($0.11) per share, with a total value of £11,587.52 ($15,478.92). 46.72% of the stock is owned by insiders.

About NIOX Group

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients.